logo-loader
TSX:PCYC

Pharmacyclics

Market:
TSX
Market Cap:
-
Price
-
Change
-
52 weeks high
-
52 weeks low
-

In brief

Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. Its pharmaceutical drug development candidates are synthetic small-molecules designed to target key biochemical pathways involved in human diseases with critical unmet needs.